Athersys has won federal approval to skip straight to Phase II when its starts testing its adult stem cell therapy in patients with ulcerative colitis.
Athersys Inc. receives federal clearance for Phase II of clinical trials
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You